Ayse T. Kendi
Articles
-
Jul 19, 2023 |
mdpi.com | Albert Jang |Ayse T. Kendi |Geoffrey Johnson |Thorvardur Halfdanarson
Abstract:Radiopharmaceuticals are rapidly developing as a field, with the successful use of targeted beta emitters in neuroendocrine tumors and prostate cancer serving as catalysts. Targeted alpha emitters are in current development for several potential oncologic indications.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →